TransMedics director James R. Tobin reports sale of $385,463.64 in common shares

TMDX•2026-11-12

TransMedics Group director James R. Tobin sold 4,059 shares on Nov. 9, 2026, for a total of $385,463.64.

1. Share sale

Tobin sold 59 shares at $93.96 each and 4,000 shares at $94.98 each. After the transactions, he held 2,922 shares directly and 155,146 shares indirectly through the James R. Tobin 2012 Trust.

Sources

TransMedics director James R. Tobin reports sale of $385,463.64 in common shares

Sec

TransMedics director James R. Tobin reports sale of $385,463.64 in common shares

1. Share sale

Related News

Meta faces July trial in Washington, DC data privacy lawsuit

Stanley Black & Decker publishes Baird Global Industrial Conference transcript

Serina Therapeutics Q3 net loss widens on higher R&D costs

Sources

TransMedics director James R. Tobin reports sale of $385,463.64 in common shares

Afya Limited reaffirms full-year 2026 guidance

Skyworks awards CEO Philip G. Brace 81,489 restricted stock units